EP0912187A4 - - Google Patents

Info

Publication number
EP0912187A4
EP0912187A4 EP97903853A EP97903853A EP0912187A4 EP 0912187 A4 EP0912187 A4 EP 0912187A4 EP 97903853 A EP97903853 A EP 97903853A EP 97903853 A EP97903853 A EP 97903853A EP 0912187 A4 EP0912187 A4 EP 0912187A4
Authority
EP
European Patent Office
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP97903853A
Other versions
EP0912187A2 (en
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of EP0912187A2 publication Critical patent/EP0912187A2/en
Publication of EP0912187A4 publication Critical patent/EP0912187A4/xx
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP97903853A 1996-01-18 1997-01-17 Compositions and methods for the prevention and treatment of atherosclerosis and reperfusion injury with magnesium salts Withdrawn EP0912187A2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US58856496A 1996-01-18 1996-01-18
US588564 1996-01-18
PCT/US1997/000821 WO1997025959A2 (en) 1996-01-18 1997-01-17 Compositions and methods for the prevention and treatment of atherosclerosis and reperfusion injury with magnesium salts

Publications (2)

Publication Number Publication Date
EP0912187A2 EP0912187A2 (en) 1999-05-06
EP0912187A4 true EP0912187A4 (xx) 1999-05-06

Family

ID=24354361

Family Applications (1)

Application Number Title Priority Date Filing Date
EP97903853A Withdrawn EP0912187A2 (en) 1996-01-18 1997-01-17 Compositions and methods for the prevention and treatment of atherosclerosis and reperfusion injury with magnesium salts

Country Status (3)

Country Link
EP (1) EP0912187A2 (xx)
AU (1) AU1832197A (xx)
WO (1) WO1997025959A2 (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2244117A1 (en) * 1996-01-25 1997-07-31 William B. Weglicki Intravenous magnesium gluconate for treatment of conditions caused by excessive oxidative stress due to free radical distribution
WO1998047497A2 (en) * 1997-04-23 1998-10-29 Fleming & Company, Pharmaceuticals Methods and compositions for the prevention and treatment of immunological disorders, inflammatory diseases and infections
EP1992339A1 (en) * 2007-05-18 2008-11-19 Saeed Sarkar Use of a magnesium isotope for treating hypoxia and a medicament comprising the same
US7879996B2 (en) 2007-05-18 2011-02-01 Saeed Sarkar Water soluble compounds
DE102010039489A1 (de) * 2010-08-18 2012-02-23 Fresenius Medical Care Deutschland Gmbh Konzentrat

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3328304A (en) * 1964-07-31 1967-06-27 Guardian Chemical Corp Chelating agents and methods for their manufacture
GB1105145A (en) * 1964-06-04 1968-03-06 Bristol Myers Co Stabilised antacid compositions
US4962208A (en) * 1988-05-27 1990-10-09 Globus Alfred R Method for preparing time-stable solutions of non-pyrogenic magnesium gluconocitrates
US5002965A (en) * 1989-05-09 1991-03-26 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) Use of ginkgolides to prevent reperfusion injury in organ transplantation
US5108365A (en) * 1990-06-20 1992-04-28 Woods Jr Walter T Transluminal infusion of magnesium during coronary angioplasty
US5370989A (en) * 1992-04-03 1994-12-06 The Trustees Of Columbia University In The City Of New York Solution for prolonged organ preservation
JPH07304657A (ja) * 1994-05-13 1995-11-21 Morishita Roussel Kk 電解質輸液剤

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1105145A (en) * 1964-06-04 1968-03-06 Bristol Myers Co Stabilised antacid compositions
US3328304A (en) * 1964-07-31 1967-06-27 Guardian Chemical Corp Chelating agents and methods for their manufacture
US4962208A (en) * 1988-05-27 1990-10-09 Globus Alfred R Method for preparing time-stable solutions of non-pyrogenic magnesium gluconocitrates
US5002965A (en) * 1989-05-09 1991-03-26 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) Use of ginkgolides to prevent reperfusion injury in organ transplantation
US5108365A (en) * 1990-06-20 1992-04-28 Woods Jr Walter T Transluminal infusion of magnesium during coronary angioplasty
US5370989A (en) * 1992-04-03 1994-12-06 The Trustees Of Columbia University In The City Of New York Solution for prolonged organ preservation
JPH07304657A (ja) * 1994-05-13 1995-11-21 Morishita Roussel Kk 電解質輸液剤

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
"Handbook of Pharmaceutical Excipients", 1988, AMERICAN PHARMACEUTICAL ASSOCIATION, WASHINGTON DC, XP002094177 *
CHEMICAL ABSTRACTS, vol. 125, no. 15, 7 October 1996, Columbus, Ohio, US; abstract no. 192424, SANDU ET AL: "Histochemical Aspects of Experimental Atherosclerosis in Rat Thoracic Aortae" XP002094178 *
DATABASE WPI Week 9604, Derwent World Patents Index; AN 96-035820 *
PATENT ABSTRACTS OF JAPAN vol. 096, no. 003 29 March 1996 (1996-03-29) *
SANDU ET AL: "Histochemical Aspects of Experimental Atherosclerosis in Rat Thoracic Aortae", STUD. CERCET. BIOL., SER. BIOL. ANIM., vol. 47, no. 1, 1995, pages 47 - 52 *
STANEVA-STOYCEVA ET AL: "The Effect of Magnesium Gluconate on Experimental Atherosclerosis in Pigeons, and on the Content of Sulfhydryl and Disulfide Groups in Aorta and Liver", FOLIA MEDICA, vol. 11, no. 4, 1969, pages 247 - 253, XP002094176 *

Also Published As

Publication number Publication date
AU1832197A (en) 1997-08-11
WO1997025959A2 (en) 1997-07-24
EP0912187A2 (en) 1999-05-06

Similar Documents

Publication Publication Date Title
AR026662A2 (xx)
BRPI9713914B8 (xx)
IN192460B (xx)
IN191597B (xx)
ITMI960201A0 (xx)
ITBZ970009V0 (xx)
ITMC960025A0 (xx)
BR7601346U (xx)
BR9603859A (xx)
BR7600721U (xx)
ITCT960011A0 (xx)
ITAL960012V0 (xx)
IN184429B (xx)
IN191780B (xx)
ITMI960133A0 (xx)
IN187469B (xx)
IN186335B (xx)
IN185795B (xx)
IN181330B (xx)
CN3044346S (xx)
CN3047348S (xx)
CN3044168S (xx)
EP0914672A4 (xx)
CN3043305S (xx)
CN3042589S (xx)

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19980811

A4 Supplementary search report drawn up and despatched

Effective date: 19990316

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19990517